Nearly $4 Million Awarded to Advance Critical Cancer Research NEW YORK, June 17, 2026 /PRNewswire/ -- The Lymphoma Research Foundation...
Blog
TEL AVIV, Israel, June 17, 2026 /PRNewswire/ -- Matricelf Ltd. (TASE: MTLF), a regenerative medicine company developing personalized engineered tissue implants...
BOULDER, Colo., June 17, 2026 /PRNewswire/ -- Igniton is proud to announce that it has been honored with three 2025...
Interim phase 1/2 data confirm significant anti-fentanyl antibody production at the lowest dose, with a well-tolerated safety profile across all...
— Series C supported by premier syndicate including co-leads Ascenta Capital and Janus Henderson Investors with significant participation from Deep...
CALGARY, AB, June 17, 2026 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ: HITI) (TSXV: HITI) (FSE: 2LYA),...
All study objectives met MRX1 well tolerated, Phase 2 dosing on track to start H2 2026 Data reinforces case for...
RIYADH, Saudi Arabia, June 17, 2026 /PRNewswire/ -- Bristol Myers Squibb (BMS), a leading global biopharmaceutical company, has appointed Mayada Al-Ahmad...
Former Lighthouse for the Blind President and CEO Brings Deep Expertise in Vision Rehabilitation, Accessibility, Employment, and Social Enterprise Leadership...
LONDON, June 17, 2026 /PRNewswire/ -- A major new systematic review and meta‑analysis1 has confirmed that the proprietary New Zealand...